Deutsche Bank
GMAB icon

Deutsche Bank’s Genmab GMAB Stock Holding History

Deutsche Bank’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$83 – 3654
2025
Q2 		$83 Buy
+4
New +$82 ﹤0.01% 3593
2024
Q2 		– Sell
-5,673
Closed -$170K – 3616
2024
Q1 		$170K Hold
5,673
– – ﹤0.01% 2922
2023
Q4 		$181K Buy
+5,673
New +$178K ﹤0.01% 2937
2023
Q3 		– Sell
-1,951
Closed -$74.2K – 3750
2023
Q2 		$74.2K Buy
+1,951
New +$77.8K ﹤0.01% 3383
2021
Q4 		– Sell
-43
Closed -$2K – 4308
2021
Q3 		$2K Sell
43
-6,874
-99% -$309K ﹤0.01% 4356
2021
Q2 		$282K Sell
6,917
-233
-3% -$8.99K ﹤0.01% 3582
2021
Q1 		$235K Sell
7,150
-1,060
-13% -$39.9K ﹤0.01% 3548
2020
Q4 		$334K Buy
+8,210
New +$307K ﹤0.01% 3168
2020
Q3 		– Sell
-17,945
Closed -$608K – 4368
2020
Q2 		$608K Buy
+17,945
New +$489K ﹤0.01% 2521

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank's GMAB Position: Q3 2025 in Review

Deutsche Bank sold out of Genmab (GMAB) in Q3 2025, closing a stake of 4 shares — an estimated $83 sold.

Deutsche Bank first reported a position in GMAB in Q2 2020 and held it in 9 quarters. The position peaked at $608K in Q2 2020. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Deutsche Bank reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 4 Genmab shares in Q3 2025, an estimated $83.
  • Deutsche Bank first reported a position in Genmab in Q2 2020 and held it in 9 quarters.
  • Deutsche Bank's Genmab position peaked at $608K in Q2 2020.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.